Slow recovery from severe inorganic arsenic poisoning despite treatment with DMSA (2.3-dimercaptosuccinic acid)

被引:15
作者
Stenehjem, Aud-E. [1 ]
Vahter, Marie
Nermell, Barbro
Aasen, Jorulf
Lierhagen, Syverin
Morland, Jorg
Jacobsen, Dag
机构
[1] Ullevaal Univ Hosp, Dept Nephrol, N-0407 Oslo, Norway
[2] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden
[3] Ullevaal Univ Hosp, Dept Neurol, N-0407 Oslo, Norway
[4] Univ Trondheim, Fdn Nat Res & Cultural Heritage Res, Trondheim, Norway
[5] Norwegian Inst Publ Hlth, Div Forens Toxicol & Drug Abuse, Oslo, Norway
[6] Ullevaal Univ Hosp, Dept Acute Med, N-0407 Oslo, Norway
关键词
arsenic poisoning; chelating therapy; DMSA; neuropathy;
D O I
10.1080/15563650701232489
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
A 39-year-old woman was hospitalized for nausea, diarrhea, vomiting, and weakness of unknown etiology. Her condition progressively deteriorated and she developed multiple organ failure and tetraplegia. The diagnosis of inorganic arsenic poisoning was established by measurements of arsenic in urine and serum, showing 2,000 mu g/L (normal < 10 mu g/L) and 290 mu g/Kg (normal < 2 mu g/Kg), respectively. Hair arsenic was 57 mg/kg (normal < 0.2 mg/kg). Chelating therapy with 2.3-dimercaptosuccinic acid (DMSA) 600 mg three times daily was given for a period of 45 days with three abruption periods during a total of 13 days. The clinical manifestations of arsenic toxicosis disappeared very slowly and five years after the hospitalization she still suffers from peripheral neuropathy. Although the use of DMSA was associated with increased urinary elimination of arsenic and a decrease in blood arsenic concentrations, DMSA treatment probably had no significant effect on the total body clearance in our patient. The source of the poisoning was never detected, nor the motivation behind it. Criminal intent was suspected, but no verdict was given.
引用
收藏
页码:424 / 428
页数:5
相关论文
共 41 条
[1]   ENVIRONMENTAL EXPOSURE TO LEAD AND ARSENIC AMONG CHILDREN LIVING NEAR A GLASSWORKS [J].
ANDREN, P ;
SCHUTZ, A ;
VAHTER, M ;
ATTEWELL, R ;
JOHANSSON, L ;
WILLERS, S ;
SKERFVING, S .
SCIENCE OF THE TOTAL ENVIRONMENT, 1988, 77 (01) :25-34
[2]   Geographical and temporal differences in the urinary excretion of inorganic arsenic: A Belgian population study [J].
Buchet, JP ;
Staessen, J ;
Roels, H ;
Lauwerys, R ;
Fagard, R .
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1996, 53 (05) :320-327
[3]   THE SPECIATION OF THE CHEMICAL FORMS OF ARSENIC IN THE BIOLOGICAL MONITORING OF EXPOSURE TO INORGANIC ARSENIC [J].
FOA, V ;
COLOMBI, A ;
MARONI, M ;
BURATTI, M ;
CALZAFERRI, G .
SCIENCE OF THE TOTAL ENVIRONMENT, 1984, 34 (03) :241-259
[4]   Determination of arsenic metabolic complex excreted in human urine after administration of sodium 2,3-dimercapto-1-propane sulfonate [J].
Gong, Z ;
Jiang, GF ;
Cullen, WR ;
Aposhian, HV ;
Le, XC .
CHEMICAL RESEARCH IN TOXICOLOGY, 2002, 15 (10) :1318-1323
[5]   Chronic arsenic poisoning [J].
Hall, AH .
TOXICOLOGY LETTERS, 2002, 128 (1-3) :69-72
[6]   Arsenic species excretion after dimercaptopropanesulfonic acid (DMPS) treatment of an acute arsenic trioxide poisoning [J].
Heinrich-Ramm, R ;
Schaller, KH ;
Horn, J ;
Angerer, J .
ARCHIVES OF TOXICOLOGY, 2003, 77 (02) :63-68
[7]   PERIPHERAL NEUROPATHY CAUSED BY ARSENICAL INTOXICATION - A STUDY OF 41 CASES WITH OBSERVATIONS ON THE EFFECTS OF BAL (2,3, DIMERCAPTO-PROPANOL) [J].
HEYMAN, A ;
PFEIFFER, JB ;
WILLETT, RW ;
TAYLOR, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 1956, 254 (09) :401-409
[8]  
HINDMARSCH JT, 1986, CRIT REV CLIN LAB SC, V16, P45
[9]   The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds [J].
Hirano, S ;
Kobayashi, Y ;
Cui, X ;
Kanno, S ;
Hayakawa, T ;
Shraim, A .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 198 (03) :458-467
[10]  
HOPPS HC, 1997, SCI TOTAL ENVIRON, V7, P71